Stockreport

Theriva Biologics Announces Pricing of $2.5 Million Public Offering

Theriva Biologics, Inc.  (TOVX) 
PDF ROCKVILLE, Md., Sept. 26, 2024 (GLOBE NEWSWIRE) -- Theriva Biologics, Inc. (NYSE American: TOVX) (“Theriva” or the “Company”), a diversified clinical-stage company dev [Read more]